Alkermes PLC (STU:8AK)
€ 22.2 0 (0%) Market Cap: 3.76 Bil Enterprise Value: 3.41 Bil PE Ratio: 9.49 PB Ratio: 3.24 GF Score: 68/100

Alkermes Plc at SVB Leerink Global Healthcare Conference (Virtual) Transcript

Feb 24, 2021 / 02:20PM GMT
Release Date Price: €15.24 (+1.86%)
Marc Harold Goodman
SVB Leerink LLC, Research Division - MD of Neuroscience & Senior Research Analyst

All right. Good morning, everybody, and welcome to the SVB Leerink Global Healthcare Conference. This is my first session of the day, and we're really pleased to have Alkermes, one of the companies that has been around a long time, and it's one of the really great companies in the (inaudible).

We're lucky enough to have Blair Jackson, who've joined the company in 1999, and moved around different roles, and now is the Chief Operating Officer.

And we have Iain Brown as well. He joined the company in 2003 and recently became CFO. So thank you so much, both of you for joining.

So Blair is going to make some opening comments, and then we're going to move into questions. So Blair, I'll turn it over to you.

Blair C. Jackson
Alkermes plc - Executive VP & COO

Great. Thanks a lot, Marc. It's really nice to see you. I will remind everyone that I will be making forward-looking statements during today's presentation, and I encourage

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot